Philanthropy & Grantmaking
(T22)
IRS Verified
DX Registered
990 on File
NEPHCURE KIDNEY INTERNATIONAL
Financial strength (30%)
80/100
Reliability (20%)
55/100
Effectiveness (25%)
85/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
NephCure Kidney International is committed to supporting proteinuric kidney disease research to discover the causes, best therapies and prevention strategies.
Financial Overview — FY 2025
$6.8M
Total Revenue
$6.2M
Total Expenses
$3.8M
Net Assets
27
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
83.7%
Fundraising Efficiency
104.2%
Operating Reserve
7.31x
Liability-to-Asset
13.8%
Revenue Diversification
98.8%
Executive Compensation
$324K
Compared with Peers
FY 2025
Compared with 2,423 similar organizations
(United States, Philanthropy & Grantmaking, $1M–$10M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
83.7% | 91.3% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
6.7% | 8.2% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
9.6% | 2.6% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
104.2% | 156.1% |
P10P90
|
Above median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
7.3 mo | 65.7 mo |
P10P90
|
Bottom quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
13.8% | 0.0% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
98.8% | 90.4% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
20.6% | 9.0% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
5.0% | 9.3% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
8.8% | 3.0% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $6.8M | $6.2M | $3.8M | 83.7% | 27 |
| 2024 | $5.6M | $5.9M | $3.0M | 82.5% | 23 |
| 2023 | $4.3M | $4.8M | $3.2M | 78.5% | 25 |
| 2022 | $4.5M | $3.7M | $3.6M | 71.7% | 23 |
| 2021 | $3.9M | $3.2M | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.